Top 50 Clinical Trial Platform - Series A

Macro Trials is a precision research clinical platform that utilizes a digitally powered infrastructure and a hub-and-spoke distributed model to enhance the efficiency of clinical trials for high-value therapeutics. The platform addresses the challenges of patient recruitment and administrative burdens for clinicians, enabling diverse candidate access and streamlined participation in groundbreaking research.

Clinetic provides a technology platform that connects clinical research teams with a network of over 20 million patients across 70+ hospitals, facilitating faster patient identification, engagement, and enrollment for studies. By streamlining prospective real-world studies through protocol-specific patient alignment and hybrid study implementation, Clinetic enhances the efficiency and speed of clinical research processes.

Lokavant provides a data-driven analytics platform that aggregates and integrates real-time data from various clinical trial sources. This technology enhances trial execution by enabling proactive management, operational health tracking, and risk-based monitoring, ultimately improving study efficiency and decision-making.

Power Life Science is a platform that connects patients with over 30,000 active clinical trials, allowing them to filter options based on specific medical conditions, locations, and drug types. This service addresses the challenge of limited access to experimental treatments by streamlining the search process and facilitating direct connections with researchers.

PhaseV develops a machine learning-based platform that utilizes causal inference and multi-arm bandit algorithms to optimize adaptive clinical trial design and execution. This technology enhances decision-making and resource allocation, increasing the success rates of clinical trials by providing real-time, data-driven insights throughout the trial process.

R.grid provides an AI-driven automation platform that integrates trial management processes from pre-trial to trial close, significantly reducing administrative errors and delays. Its products, Inclusive and TrialEngine, streamline patient recruitment and automate complex workflows, cutting trial timelines by months and enhancing overall trial success rates.

myTomorrows is a global platform that connects patients with unmet medical needs to clinical trials and treatments in development, utilizing personalized patient navigation and advanced search technology. The platform addresses the challenge of accessing timely treatment options by providing patients and healthcare professionals with streamlined resources and support for clinical trial enrollment and expanded access programs.

Clara Health provides a digital platform that connects patients with clinical trials tailored to their specific health needs, utilizing 24/7 live patient navigators for personalized support. The service addresses the challenge of accessing relevant clinical studies, ensuring patients can find and participate in research that offers new treatment options at no cost.

Trialbee offers the Honey Platform, a vendor-agnostic patient recruitment solution that centralizes recruitment activities and provides real-time tracking and reporting. By utilizing data-driven modeling and targeted outreach, Trialbee enhances patient engagement and referral quality while reducing the burden on clinical sites.

Korio is a Randomization and Trial Supply Management (RTSM) platform that enhances clinical trial efficiency by providing flexible, customizable solutions that adapt to complex study designs. It addresses delays and quality issues caused by rigid legacy systems, ensuring timely updates and reliable support throughout the trial process.

The startup offers a remote patient research platform that integrates validated studies and connects with wearables and medical devices, facilitating seamless data transfer into existing systems. This technology enables biopharma and home health professionals to efficiently design and scale clinical research programs while ensuring compliance with data requirements.

Topography Health provides a research platform that enables community physicians to conduct clinical trials, enhancing patient access to novel therapies while generating additional revenue for practices. By integrating tailored staffing services and advanced technology, the platform improves the quality, speed, and diversity of clinical research.

ObjectiveHealth operates a data analytics and machine learning platform that enhances clinical decision-making by extracting actionable insights from real-world evidence. The platform targets inefficiencies in healthcare delivery, aiming to improve patient outcomes through informed treatment strategies.

SiteRx provides a platform that uses AI-driven patient identification tools to improve diversity and efficiency in clinical trial recruitment. By lowering barriers to participation, it addresses the underrepresentation of diverse communities in clinical research, ensuring more equitable access to trial opportunities. The SOC2-compliant platform maintains HIPAA compliance and employs advanced data security measures to protect sensitive information.

Clinical Research IO develops eSource technology that enhances protocol compliance and eliminates transcription errors in clinical trials. This platform significantly reduces audit risk by 70% and increases patient enrollment by 39%, saving time and costs for research sites and sponsors.

Yonalink provides an AI-powered platform that streams clinical trial data in real time from electronic health records (EHRs) to electronic data capture (EDC) systems, significantly reducing manual data entry and associated errors. This solution enhances data quality and operational efficiency for clinical trial sponsors, contract research organizations (CROs), and hospitals by automating data transfer and management processes.

Inato has developed a global clinical trial marketplace that connects pharmaceutical sponsors with community-based research sites, enhancing patient access to clinical trials. By streamlining site selection and enrollment processes, Inato addresses the limited participation opportunities for diverse patient populations, ultimately accelerating the pace of medical research.

The startup operates a clinical trial data platform that integrates licensed healthcare professionals with connected technology to facilitate decentralized clinical trials. This approach enhances trial accessibility and efficiency, allowing patients to consult with doctors and enabling continuous patient monitoring outside traditional clinical settings.

HealthMatch is a platform that connects patients with eligible clinical trials for new drugs and treatments by simplifying the search process and assessing trial eligibility. This service addresses the challenge of finding appropriate clinical studies, enabling patients to access potential therapies that may not be widely available.

The startup has developed a proteomics platform that utilizes quantitative and targeted biomarker analysis to provide molecular insights into drug response. This technology accelerates clinical trials across various disease areas, enabling pharmaceutical companies to enhance trial success rates and improve access to therapies.

Florence Healthcare provides a Site Enablement Platform that automates document workflows and participant enrollment for clinical trials, enhancing collaboration among sponsors, CROs, and research sites. By connecting over 20,000 research sites globally, the platform streamlines clinical research processes, reducing operational risks and accelerating trial timelines.

SubjectWell is a patient recruitment platform that utilizes machine learning to match healthcare-motivated patients with clinical studies across various therapeutic areas, ensuring a diverse and pre-qualified patient pool. By streamlining the connection between sponsors, CROs, and patients, SubjectWell reduces the time to start screening patients from weeks to days, enhancing the efficiency of clinical trials.

iLoF utilizes a cloud-based platform that employs photonics and AI to create a digital library of optical fingerprints for non-invasive patient screening and stratification in clinical trials. This technology reduces screening time by 70% and costs by 40%, while providing a more qualified pool of candidates for drug development.

Mural Health offers Mural Link, a patient management platform that simplifies participation in clinical trials by providing flexible payment options, travel coordination, and real-time communication tools. This technology addresses high dropout rates and inefficient recruitment processes by enhancing participant engagement and streamlining operational workflows for study sponsors.

Datacubed Health provides a platform for electronic clinical outcomes assessments (eCOA) that enhances patient engagement through a mobile-friendly application designed for clinical trials. By utilizing behavioral science principles, the platform improves data collection accuracy and patient retention, addressing challenges in participant compliance and engagement across traditional, hybrid, and decentralized trial formats.

Faro Health provides an AI-enabled platform for designing and implementing clinical trial protocols, streamlining the complexities of protocol development through data-driven insights and reusable content. This technology reduces authoring time and enhances the quality of clinical trials, minimizing patient burden and associated costs.

Slope.io provides Biospecimen360™, a software solution for end-to-end biospecimen lifecycle management that captures sample metadata in real-time and coordinates logistics, processing, and tracking. The platform addresses inventory shortages and compliance issues in clinical trials, enabling faster decision-making and improved data quality for sponsors and research sites.

The startup offers a cloud-based platform that streamlines patient identification and recruitment for clinical trials through a plug-and-play setup and a user-friendly video portal. This technology enables pharmaceutical companies and research institutions to efficiently qualify and enroll suitable participants, significantly reducing the time and cost associated with trial recruitment.

4G Clinical offers Prancer RTSM®, a software solution for randomization and trial supply management that enhances clinical trial efficiency by allowing for flexible mid-study adjustments and minimizing supply waste. Their 4C Supply® tool helps clinical supply managers predict patient demand and assess supply chain risks, addressing the challenges of stock-outs and waste in increasingly complex trials.

EmVenio Research establishes decentralized clinical trial sites in underserved communities, utilizing community engagement and data analytics to enhance patient recruitment and retention. This approach addresses the lack of access to clinical trials for diverse populations, improving enrollment rates and ensuring that underrepresented groups are included in medical research.

The startup operates an independent Site Management Organization that conducts clinical trials by identifying, recruiting, and retaining patients at dedicated research sites. This service enables Contract Research Organizations and pharmaceutical companies to efficiently match patients with appropriate trials across various therapeutic areas.

uMed utilizes the ACCESS Research Platform to automate the clinical studies process by creating consented patient cohorts and integrating electronic health records with real-time clinical outcomes. This approach addresses the challenges of slow patient enrollment and limited access to diverse populations in clinical research, enabling faster and more representative studies.

Radicle Science utilizes crowdsourced, virtual, direct-to-consumer clinical trials to generate rigorous, double-blind, placebo-controlled data on the efficacy of health and wellness products across diverse populations. This approach provides manufacturers with validated health claims and insights into consumer demographics, enabling them to optimize formulations and enhance market trust.

Acclinate utilizes community engagement and predictive insights to enhance diversity in clinical trials by connecting pharmaceutical companies with underrepresented communities of color. This approach addresses the lack of representation in clinical research, helping to meet FDA diversity requirements while reducing recruitment costs and time.

Auxilius offers clinical trial financial management software specifically designed for biopharma, enabling teams to manage study budgets, forecasts, and accruals with data-driven insights. The platform replaces traditional spreadsheet methods, enhancing financial accuracy and compliance while streamlining the financial close process for clinical research.

This company facilitates biomedical research by directly engaging patients and collecting annotated biospecimens in their homes. Their platform provides researchers with access to clinically relevant biomarker data and apheresis products for prospective study designs.

The startup has developed a patient empowerment platform that provides personalized, expert-validated, evidence-based disease information and clinical data to patients. This platform enables patients to make informed decisions and manage their care effectively by generating real-world evidence that informs clinical practices and improves health outcomes.

Trial Library develops a technology-enabled platform that enhances patient recruitment and diversity in oncology clinical trials through community provider engagement and personalized navigation services. By addressing the lack of equitable representation in cancer research, the platform facilitates access to precision medicine for underrepresented patient populations, improving enrollment rates and health outcomes.

Provides a cloud-based platform, Archer, that automates the transfer of patient data from electronic health records (EHR) to electronic data capture (EDC) systems for clinical trials. By eliminating manual data transcription and source data verification, Archer reduces data transfer time by 96.5% during live oncology studies, ensuring fast, secure, and regulatory-compliant data collection.

Clouds of Care de-risks CNS clinical development by identifying and validating clinically relevant endpoints through multimodal data aggregation and analysis. Their platform connects to a network of Digital Health Technologies to generate scientifically validated insights, improving the probability of success for CNS drug development.

Contract Network develops an AI-powered collaborative platform for clinical trial agreements, enabling stakeholders to streamline negotiations and reduce contract processing time by up to 80%. By centralizing compliance and critical terms from the first draft, the platform enhances transparency and efficiency, minimizing reliance on lengthy email exchanges.

The startup has developed a healthcare technology platform that utilizes virtualized therapy management and adaptive machine learning to enhance the delivery of care by specialists. This platform enables clinicians to effectively interpret clinical evidence and respond to the physiological impacts of diseases and therapies, bridging the gap between medical knowledge and patient experiences.

Theremia utilizes an AI-driven platform to enhance drug efficacy and minimize side effects by tailoring treatments to the specific needs of diverse patient demographics. The company improves clinical trial processes, leading to more precise outcomes and faster market access for pharmaceutical products.

BEKhealth utilizes an AI-powered patient-matching platform that extracts structured and unstructured data from electronic medical records to identify clinically qualified participants for clinical trials. This technology enables organizations to enhance feasibility assessments and achieve up to 10 times more qualified patients and twice as fast enrollment compared to traditional methods.

People Science is a technology-enabled clinical research platform that utilizes data collection tools to conduct rigorous studies on alternative medicines and wellness interventions. The platform empowers consumers to explore personalized health solutions while providing companies with reliable scientific evidence to enhance their product development.

Triomics is a generative AI platform that matches patients to clinical trials by analyzing health records and medical terminology. This technology alleviates the cognitive overload faced by healthcare staff, accelerating trial enrollment and improving oncology care operations.

Akrivia Health utilizes AI-powered natural language processing to analyze the world's largest dataset of de-identified psychiatric records, facilitating real-world evidence generation and clinical trial optimization for mental health and dementia research. By improving patient recruitment and study feasibility, the platform addresses the high costs and lengthy timelines associated with clinical trials in these critical areas.

Intelligencia utilizes machine learning algorithms to provide accurate probability of success assessments for drug development, enabling pharmaceutical companies to identify and quantify risks across various therapeutic areas. By offering transparent AI-driven insights, the platform enhances decision-making and optimizes clinical trial design, ultimately increasing the likelihood of successful drug approvals.

The startup operates a preclinical drug investment and development platform that licenses transformational medicines while streamlining the licensing process and expediting patent approvals. This approach reduces the overall cost of drug discovery and accelerates the transition of therapies into clinical trials, facilitating faster access to treatments for patients.

The startup offers a cloud-based data analytics platform that processes and visualizes large omics datasets, including genomics, transcriptomics, and proteomics, to elucidate the molecular mechanisms underlying cellular phenotypes. This technology enhances decision-making in drug research and development, enabling scientists and clinicians to efficiently identify potential treatments for diseases.